Silvercrest Asset Management Group LLC lessened its holdings in Azenta, Inc. (NASDAQ:AZTA – Free Report) by 3.6% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 22,795 shares of the company’s stock after selling 845 shares during the period. Silvercrest Asset Management Group LLC’s holdings in Azenta were worth $1,374,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Dimensional Fund Advisors LP grew its position in Azenta by 31.2% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,231,792 shares of the company’s stock valued at $145,382,000 after acquiring an additional 530,408 shares during the last quarter. Norges Bank bought a new position in Azenta in the fourth quarter valued at about $140,856,000. Conestoga Capital Advisors LLC grew its position in Azenta by 13.4% in the fourth quarter. Conestoga Capital Advisors LLC now owns 1,291,284 shares of the company’s stock valued at $84,114,000 after acquiring an additional 152,090 shares during the last quarter. Stephens Investment Management Group LLC grew its position in Azenta by 1.7% in the fourth quarter. Stephens Investment Management Group LLC now owns 887,158 shares of the company’s stock valued at $57,789,000 after acquiring an additional 14,626 shares during the last quarter. Finally, Schroder Investment Management Group grew its position in Azenta by 14.6% in the fourth quarter. Schroder Investment Management Group now owns 625,515 shares of the company’s stock valued at $40,746,000 after acquiring an additional 79,913 shares during the last quarter. Institutional investors own 99.08% of the company’s stock.
Azenta Stock Performance
NASDAQ:AZTA opened at $61.99 on Wednesday. The stock’s 50-day moving average is $53.96 and its 200-day moving average is $57.75. Azenta, Inc. has a 1-year low of $44.00 and a 1-year high of $69.16.
Wall Street Analyst Weigh In
A number of research analysts have issued reports on AZTA shares. Jefferies Financial Group initiated coverage on Azenta in a research report on Thursday, April 4th. They issued a “hold” rating and a $64.00 target price on the stock. Evercore ISI boosted their price target on Azenta from $52.00 to $53.00 and gave the stock an “in-line” rating in a report on Tuesday, July 2nd. Finally, Needham & Company LLC reduced their price target on Azenta from $75.00 to $69.00 and set a “buy” rating on the stock in a report on Thursday, May 9th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $67.00.
Read Our Latest Research Report on AZTA
Azenta Company Profile
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Featured Articles
- Five stocks we like better than Azenta
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- 5 Aggressive Growth Stocks for Long-Term Investors
- What is the Australian Securities Exchange (ASX)
- Invest Like Congress: 2 ETFs to Add to Your Watchlist
- Investing In Preferred Stock vs. Common Stock
- AI Boom or Bubble? Strategies for Success in a Volatile Sector
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.